Tarek Hassanein, MD
Basic profileGastroenterologist · Southern California Reproductive Center
Tarek Hassanein is Gastroenterologist at Southern California Reproductive Center. OpenAlex indexes 403 publications with 20,430 citations (h-index 64); ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Updated 12 Oct 2026
Tarek Hassanein, MD, is Gastroenterologist at Southern California Liver Centers. The public record shows 397 publications with 20,620 citations (h-index 64), centered on Hepatitis C virus research, Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 34 companies, 1 NIH-funded awards (2000–2006).
- Most recent indexed publication: 2024 · WFUMB ultrasound open
- Top research focus: Hepatitis C virus research
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 34 companies
Generated from the cited public record · current as of 12 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 159.
Clinical & industry
trials, payments and federal fundingClinical trials
Updated 12 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis
Sponsor: Nterica Bio inc
Industry payments
Updated 12 Oct 2026
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year202518 payments$17,082openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year202510 payments$16,306openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202516 payments
NIH funding
Updated 12 Oct 2026
1 NIH research award on record, funded 2000–2006 per NIH RePORTER. The latest:
- N-ACETYLCYSTEINE IN THE TREATMENT OF ACUTE LIVER FAILURE IN ADULTS
University of California, San Diego
FY2006$1,052M01RR000827 - N-ACETYLCYSTEINE IN THE TREATMENT OF ACUTE LIVER FAILURE IN ADULTS
University of California San Diego
FY2005$4,213M01RR000827 - IFN ALPHA-2B + RIBAVIRIN VS REBETRON IN HEPATITIS C
University of California San Diego
FY2002M01RR000827
Congress activity
Updated 12 Oct 2026
1 congress contribution (2014) across AACR per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 12 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Methods and Validation of Velacur Determined Fat Fraction in patients with MASLD.
WFUMB ultrasound open
Article2024 - The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study.
International journal of hepatology
Article2024 - Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts.
Intensive care medicine
Review2022 - Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial.
Evidence-based complementary and alternative medicine
Article2022
Most-cited works
by citation count (OpenAlex)- 01Sofosbuvir for Previously Untreated Chronic Hepatitis C InfectionArticle1,788 citations2013
- 02
- 03Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV InfectionArticle1,190 citations2014
- 04ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCVArticle693 citations2014
- 05
Network
Updated 12 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 12 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →optum.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Susan Maxwell, MD
Southern California Reproductive Center
Alin Akopians, MD
Southern California Reproductive Center
Shahin Ghadir, MD
Southern California Reproductive Center
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”